Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Melanoma: HELP
Roxana S. Dronca
Based on 25 articles published since 2009
(Why 25 articles?)
||||
Expertise Level
The expertise of Roxana S. Dronca ranks in the
  • Top 0.22%
  • ... of 106,334 published authors worldwide on Melanoma
  • ... from 2009 through 2019
  • ... based on contributions to 25 articles on the topic.
Graphical view (beta)
Get your prestigious
Expert badge
similar to this:
 
Aliases Dronca, Roxana   ·   Dronca, R   ·   Dronca, R S   ·   Dronca, Roxana S
Work Locations
Details
Most likely:    Mayo Clinic Rochester      
2018
  • Caroline Robert, Gustave Roussy Cancer Campus and Paris Sud University, Villejuif Paris-Sud, France · Antoni Ribas, University of California, Los Angeles · Omid Hamid, The Angeles Clinic and Research Institute, Los Angeles · Adil Daud, University of California, San Francisco, San Francisco, CA · Jedd D. Wolchok, Ludwig Center, Memorial Sloan Kettering Cancer Center, New York, NY · Anthony M. Joshua, The Princess Margaret Cancer Centre, Toronto, Ontario, Canada · Wen-Jen Hwu, The University of Texas MD Anderson Cancer Center, Houston · Amita Patnaik, South Texas Accelerated Research Therapeutics, San Antonio, TX · Jeffrey S. Weber, H Lee Moffitt Cancer Center, Tampa · Richard W. Joseph, Mayo Clinic Cancer Center-Florida, Jacksonville, FL · Tara C. Gangadhar, Abramson Cancer Center at the University of Pennsylvania, Philadelphia · Hassane Zarour, UPMC Hillman Cancer Center, Pittsburgh, PA · Roxana Dronca, Mayo Clinic, Rochester, MN · Richard Kefford, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead · Melanoma Institute Australia, Wollstonecraft · and Macquarie University, MQ Health, Health Sciences Centre · Peter Hersey, University of Sydney, Sydney, New South Wales, Australia · Jin Zhang, James Anderson, Scott J. Diede, and Scot Ebbinghaus, Merck & Co., Inc., Kenilworth, NJ · F. Stephen Hodi, Dana-Farber Cancer Institute, Boston, MA. · Pubmed 29283791
  • Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota. · Alliance Statistics and Data Center, Mayo Clinic, Rochester, Minnesota. · Department of Medicine, Mayo Clinic, Rochester, Minnesota. · Minnesota Oncology, Coon Rapids, Minnesota. · Division of Molecular Genetics, Mayo Clinic, Rochester, Minnesota. · Division of Anatomic Pathology, Mayo Clinic, Rochester, Minnesota. · Division of Hematology/Oncology, Mayo Clinic in Arizona, Scottsdale, Arizona. · Division of Hematology/Oncology, Mayo Clinic in Florida, Jacksonville, Florida. · Unity Hospital, Metro Minnesota Community Oncology Research Consortium, Saint Louis Park, Minnesota. · Sanford Clinic North-Fargo, Fargo, North Dakota. · Pubmed 29044496
2017
  • Department of Oncology, Division of Medical Oncology, Mayo Clinic, 200 1st Street SW, Rochester, Minnesota, 55905, France. · Huntsman Cancer Institute, Divisions of Hematology and Oncology, University of Utah, 30 N 1900 E, Salt Lake City, Utah, 84132, France. · Biomedical Statistics and Informatics, Mayo Clinic, 200 1st Street SW, Rochester, Minnesota, 55905, France. · Department of Dermatology, Mayo Clinic, 200 1st Street SW, Rochester, Minnesota, 55905, France. · Department of Surgery, Mayo Clinic, 200 1st Street SW, Rochester, Minnesota, 55905, France. · Department of Surgery, Notre Dame des Aydes, Notre Dame des Aydes 11 Rue Franciade, Blois, 41000, France. · Pubmed 28879661
2016
  • Division of Medical Oncology, Mayo Clinic, Rochester, MN, USA. · Division of Radiation Oncology, Mayo Clinic, Rochester, MN, USA. · Department of Immunology, College of Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. · Department of Urology, Mayo Clinic, Rochester, MN, USA. · Pubmed 27784186
  • Adil I. Daud, University of California, San Francisco, San Francisco · Antoni Ribas, University of California, Los Angeles · Omid Hamid, The Angeles Clinic and Research Institute, Los Angeles · Charlotte Roach and Grant Toland, Dako North America, Carpinteria, CA · Jedd D. Wolchok, Memorial Sloan Kettering Cancer Center, New York, NY · Wen-Jen Hwu, The University of Texas MD Anderson Cancer Center, Houston · Amita Patnaik, South Texas Accelerated Research Therapeutics, San Antonio, TX · Jeffrey S. Weber, H. Lee Moffitt Cancer Center, Tampa · Richard Joseph, Mayo Clinic, Jacksonville, FL · F. Stephen Hodi, Dana-Farber Cancer Institute, Boston, MA · Tara C. Gangadhar, Abramson Cancer Center at the University of Pennsylvania, Philadelphia · Hassane Zarour, University of Pittsburgh, Pittsburgh, PA · Roxana Dronca, Mayo Clinic, Rochester, MN · Jared K. Lunceford, Xiaoyun Nicole Li, Kenneth Emancipator, Marisa Dolled-Filhart, S. Peter Kang, and Scot Ebbinghaus, Merck & Co, Kenilworth, NJ · Caroline Robert, Gustave Roussy and Paris-Sud University, Villejuif, France · Anthony M. Joshua, Princess Margaret Cancer Centre, Toronto, ON, Canada · Richard Kefford, Crown Princess Mary Cancer Centre, Westmead Hospital and Melanoma Institute Australia · Richard Kefford, Macquarie University · and Richard Kefford and Peter Hersey, University of Sydney, Sydney, NSW, Australia. · Pubmed 27863197
  • Division of Hematology and Oncology, University of California-Los Angeles, Los Angeles. · Department of Hematology/Oncology, The Angeles Clinic and Research Institute, Los Angeles, California. · Department of Hematology/Oncology, University of California-San Francisco, San Francisco. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital and Melanoma Institute Australia, Sydney, Australia7Department of Clinical Medicine, Macquarie University, Sydney, Australia. · Department of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada. · Department of Clinical Research, South Texas Accelerated Research Therapeutics, San Antonio. · Department of Melanoma, The University of Texas MD Anderson Cancer Center, Houston. · Department of Cutaneous Oncology, H. Lee Moffitt Cancer Center, Tampa, Florida. · Division of Hematology and Oncology, Abramson Cancer Center at the University of Pennsylvania, Philadelphia. · Department of Medicine, University of Sydney, Sydney, Australia. · Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota. · Department of Hematology/Oncology, Mayo Clinic, Jacksonville, Florida. · Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania. · Department of Hematology/Oncology, Massachusetts General Hospital, Boston. · Department of Medical Oncology, Gustave-Roussy Cancer Campus and Paris Sud University, Villejuif Paris-Sud, France. · Department of Clinical Oncology, Merck & Co, Inc, Kenilworth, New Jersey. · BARDS, Merck & Co, Inc, Kenilworth, New Jersey. · Pubmed 27092830
  • F. Stephen Hodi, Dana-Farber Cancer Institute, Boston, MA · Wen-Jen Hwu, The University of Texas MD Anderson Cancer Center, Houston · Amita Patnaik, South Texas Accelerated Research Therapeutics, San Antonio, TX · Richard Kefford, Westmead Hospital, Melanoma Institute Australia, and Macquarie University · Peter Hersey, University of Sydney, Sydney, Australia · Jeffrey S. Weber, H. Lee Moffitt Cancer Center, Tampa · Richard Joseph, Mayo Clinic, Jacksonville, FL · Adil Daud, University of California San Francisco, San Francisco · Omid Hamid, The Angeles Clinic and Research Institute · Antoni Ribas, University of California Los Angeles, Los Angeles, CA · Caroline Robert, Gustave-Roussy and Paris-Sud University, Villejuif-Paris-Sud, France · Tara C. Gangadhar, Abramson Cancer Center, Philadelphia, PA · Anthony M. Joshua, Princess Margaret Hospital, Toronto, Ontario, Canada · Roxana Dronca, Mayo Clinic, Rochester, MN · Darcy Hille, Dahai Xue, Xiaoyun Nicole Li, S. Peter Kang, Scot Ebbinghaus, and Andrea Perrone, Merck, Kenilworth, NJ · and Jedd D. Wolchok, Memorial Sloan Kettering Cancer Center, New York, NY. · Pubmed 26951310
2014
  • Mayo Graduate School, Mayo Clinic, Rochester, MN. · Oregon Health and Science University, Portland. · Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, MN. · Department of Oncology, Mayo Clinic, Rochester, MN. · Department of Oncology, Mayo Clinic, Rochester, MN; Department of Medicine, Division of Hematology, Mayo Clinic, Rochester, MN. Electronic address: · Pubmed 24684874
  • Department of Internal Medicine, Oakland University William Beaumont School of Medicine, Beaumont Health System, Royal Oak, MI. Electronic address: · Division of Medical Oncology, Mayo Clinic, Rochester, MN. · Pubmed 24684873
  • Gustave Roussy and INSERM U981, Paris-Sud, France. Electronic address: · University of California Los Angeles, Los Angeles, CA, USA. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · Angeles Clinic and Research Institute, Los Angeles, CA, USA. · Crown Princess Mary Cancer Centre, Westmead Hospital and Melanoma Institute Australia, Westmead, NSW, Australia; University of Sydney, Sydney, NSW, Australia. · H Lee Moffitt Cancer Center, Tampa, FL, USA. · Princess Margaret Cancer Centre, Toronto, ON, Canada. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA. · South Texas Accelerated Research Therapeutics, San Antonio, TX, USA. · Mayo Clinic, Rochester, MN, USA. · University of Pittsburgh, Pittsburgh, PA, USA. · Mayo Clinic, Jacksonville, FL, USA. · Gustave Roussy and INSERM U981, Paris-Sud, France. · Merck, Whitehouse Station, NJ, USA. · University of California San Francisco, San Francisco, CA, USA. · Pubmed 25034862
  • *Mayo Clinic Rochester, Rochester †Metro-Minnesota Community Clinical Oncology Program, St. Louis Park, MN ‡Mayo Clinic Arizona, Scottsdale, AZ §Columbus CCOP, Columbus, OH ∥Montana Cancer Consortium, Billings, MT. · Pubmed 23357973
  • Department of Dermatology, Mayo Clinic, Rochester, MN. · Division of Medical Oncology, Mayo Clinic, Rochester, MN. · Division of Medical Oncology, Mayo Clinic, Rochester, MN; Division of Hematology, Mayo Clinic, Rochester, MN; Division of Clinical Immunology and Immunotherapeutics, Mayo Clinic, Rochester, MN. · Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN. · Department of Dermatology, Mayo Clinic, Rochester, MN. Electronic address: · Pubmed 24388022
  • Mayo Clinic, Rochester, MN. · Pubmed 25092366
2012
  • Department of Medical Oncology, Mayo Clinic, Rochester, MN, USA. · Pubmed 23148614
2017
  • *Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA †The University of Texas MD Anderson Cancer Center, Houston, TX ‡Memorial Sloan Kettering Cancer Center §Weill Cornell Medical College §§NYU Clinical Cancer Center, New York, NY ∥The Angeles Clinic and Research Institute, Los Angeles ¶Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco ††The John Wayne Cancer Institute, Providence Saint John's Health Center, Santa Monica, CA #Mayo Clinic, Rochester, MN **Mayo Clinic, Jacksonville, FL ‡‡Dana-Farber Cancer Institute, Boston, MA ∥∥Yale Cancer Center, New Haven, CT ¶¶Clinigen, Weybridge, UK ##Merck & Co. Inc., Kenilworth, NJ ***Duke Cancer Institute, Durham, NC. · Pubmed 29028788
  • aDepartment of Health Science Research, Division of Biomedical Statistics and Informatics bDepartment of Medical Oncology cDepartment of Hematology, Mayo Clinic, Rochester, Minnesota, USA. · Pubmed 27824739
  • Departments of aOncology bRadiology cDepartment of Biomedical Statistics & Informatics, Mayo Clinic, Rochester, Minnesota, USA. · Pubmed 28296712
2016
  • Departments of aOncology bHematology cImmunology, Mayo Clinic, Rochester, Minnesota, USA. · Pubmed 26848796
2015
  • Departments of aInternal Medicine bOphthalmology cOncology, Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA. · Pubmed 25396683
2014
  • Departments of *Oncology †Surgery ‡Laboratory Medicine and Pathology §Ophthalmology #Dermatology ‡‡Radiation Oncology **Pediatrics §§Radiology ∥∥Hematology ¶¶Immunology ††Medical Genetics, Mayo Clinic, Rochester, MN ∥Department of Pediatric Hematology/Oncology, Hospital for Sick Children, Toronto, ON, Canada ¶The Queen's Medical Center/Queen's Cancer Center, University of Hawaii/John A. Burns School of Medicine, Honolulu, HI. · Pubmed 23563206
2012
  • Departments of Oncology Medicine, Division of Hematology Immunology Biomedical Statistics and Informatics Women's Health Clinic, Division of General Internal Medicine, Mayo Clinic Rochester, MN 55905, USA. · Pubmed 23039889
  • Division of Medical Oncology, Mayo Clinic, Rochester, MN 55905, USA. · Pubmed 23036672
  • Department of Health Science research, Mayo Clinic, Rochester, MN 55901, USA. · Pubmed 22201928
Probable:    Mayo Clinic Scottsdale      
2014
  • *Mayo Clinic Rochester, Rochester †Metro-Minnesota Community Clinical Oncology Program, St. Louis Park, MN ‡Mayo Clinic Arizona, Scottsdale, AZ §Columbus CCOP, Columbus, OH ∥Montana Cancer Consortium, Billings, MT. · Pubmed 23357973
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 25 total) written by Roxana S. Dronca about Melanoma:

  • Durable Complete Response After Discontinuation of Pembrolizumab in Patients With Metastatic Melanoma. 2018
  • NCCTG N0879 (Alliance): A randomized phase 2 cooperative group trial of carboplatin, paclitaxel, and bevacizumab ± everolimus for metastatic melanoma. 2018
  • Efficacy and Safety of Pembrolizumab in Patients Enrolled in KEYNOTE-030 in the United States: An Expanded Access Program. 2017
  • Effect of the lymphocyte-to-monocyte ratio on the clinical outcome of chemotherapy administration in advanced melanoma patients. 2017
  • Survival of cutaneous melanoma based on sex, age, and stage in the United States, 1992-2011. 2017
  • Association between the use of surveillance PET/CT and the detection of potentially salvageable occult recurrences among patients with resected high-risk melanoma. 2017
  • BCL-2-interacting mediator of cell death (Bim) is a novel biomarker for response to anti-PD-1 therapy in patients with advanced melanoma. 2016
  • Programmed Death-Ligand 1 Expression and Response to the Anti-Programmed Death 1 Antibody Pembrolizumab in Melanoma. 2016
  • Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma. 2016
  • Evaluation of Immune-Related Response Criteria and RECIST v1.1 in Patients With Advanced Melanoma Treated With Pembrolizumab. 2016
Show List of Full Article Records
Google Searches

Learn more about Roxana S. Dronca using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Mayo Clinic Rochester
Mayo Clinic Scottsdale
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Mayo Clinic Rochester
2018
  • Caroline Robert, Gustave Roussy Cancer Campus and Paris Sud University, Villejuif Paris-Sud, France · Antoni Ribas, University of California, Los Angeles · Omid Hamid, The Angeles Clinic and Research Institute, Los Angeles · Adil Daud, University of California, San Francisco, San Francisco, CA · Jedd D. Wolchok, Ludwig Center, Memorial Sloan Kettering Cancer Center, New York, NY · Anthony M. Joshua, The Princess Margaret Cancer Centre, Toronto, Ontario, Canada · Wen-Jen Hwu, The University of Texas MD Anderson Cancer Center, Houston · Amita Patnaik, South Texas Accelerated Research Therapeutics, San Antonio, TX · Jeffrey S. Weber, H Lee Moffitt Cancer Center, Tampa · Richard W. Joseph, Mayo Clinic Cancer Center-Florida, Jacksonville, FL · Tara C. Gangadhar, Abramson Cancer Center at the University of Pennsylvania, Philadelphia · Hassane Zarour, UPMC Hillman Cancer Center, Pittsburgh, PA · Roxana Dronca, Mayo Clinic, Rochester, MN · Richard Kefford, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead · Melanoma Institute Australia, Wollstonecraft · and Macquarie University, MQ Health, Health Sciences Centre · Peter Hersey, University of Sydney, Sydney, New South Wales, Australia · Jin Zhang, James Anderson, Scott J. Diede, and Scot Ebbinghaus, Merck & Co., Inc., Kenilworth, NJ · F. Stephen Hodi, Dana-Farber Cancer Institute, Boston, MA. · Pubmed 29283791
  • Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota. · Alliance Statistics and Data Center, Mayo Clinic, Rochester, Minnesota. · Department of Medicine, Mayo Clinic, Rochester, Minnesota. · Minnesota Oncology, Coon Rapids, Minnesota. · Division of Molecular Genetics, Mayo Clinic, Rochester, Minnesota. · Division of Anatomic Pathology, Mayo Clinic, Rochester, Minnesota. · Division of Hematology/Oncology, Mayo Clinic in Arizona, Scottsdale, Arizona. · Division of Hematology/Oncology, Mayo Clinic in Florida, Jacksonville, Florida. · Unity Hospital, Metro Minnesota Community Oncology Research Consortium, Saint Louis Park, Minnesota. · Sanford Clinic North-Fargo, Fargo, North Dakota. · Pubmed 29044496
2017
  • Department of Oncology, Division of Medical Oncology, Mayo Clinic, 200 1st Street SW, Rochester, Minnesota, 55905, France. · Huntsman Cancer Institute, Divisions of Hematology and Oncology, University of Utah, 30 N 1900 E, Salt Lake City, Utah, 84132, France. · Biomedical Statistics and Informatics, Mayo Clinic, 200 1st Street SW, Rochester, Minnesota, 55905, France. · Department of Dermatology, Mayo Clinic, 200 1st Street SW, Rochester, Minnesota, 55905, France. · Department of Surgery, Mayo Clinic, 200 1st Street SW, Rochester, Minnesota, 55905, France. · Department of Surgery, Notre Dame des Aydes, Notre Dame des Aydes 11 Rue Franciade, Blois, 41000, France. · Pubmed 28879661
2016
  • Division of Medical Oncology, Mayo Clinic, Rochester, MN, USA. · Division of Radiation Oncology, Mayo Clinic, Rochester, MN, USA. · Department of Immunology, College of Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. · Department of Urology, Mayo Clinic, Rochester, MN, USA. · Pubmed 27784186
  • Adil I. Daud, University of California, San Francisco, San Francisco · Antoni Ribas, University of California, Los Angeles · Omid Hamid, The Angeles Clinic and Research Institute, Los Angeles · Charlotte Roach and Grant Toland, Dako North America, Carpinteria, CA · Jedd D. Wolchok, Memorial Sloan Kettering Cancer Center, New York, NY · Wen-Jen Hwu, The University of Texas MD Anderson Cancer Center, Houston · Amita Patnaik, South Texas Accelerated Research Therapeutics, San Antonio, TX · Jeffrey S. Weber, H. Lee Moffitt Cancer Center, Tampa · Richard Joseph, Mayo Clinic, Jacksonville, FL · F. Stephen Hodi, Dana-Farber Cancer Institute, Boston, MA · Tara C. Gangadhar, Abramson Cancer Center at the University of Pennsylvania, Philadelphia · Hassane Zarour, University of Pittsburgh, Pittsburgh, PA · Roxana Dronca, Mayo Clinic, Rochester, MN · Jared K. Lunceford, Xiaoyun Nicole Li, Kenneth Emancipator, Marisa Dolled-Filhart, S. Peter Kang, and Scot Ebbinghaus, Merck & Co, Kenilworth, NJ · Caroline Robert, Gustave Roussy and Paris-Sud University, Villejuif, France · Anthony M. Joshua, Princess Margaret Cancer Centre, Toronto, ON, Canada · Richard Kefford, Crown Princess Mary Cancer Centre, Westmead Hospital and Melanoma Institute Australia · Richard Kefford, Macquarie University · and Richard Kefford and Peter Hersey, University of Sydney, Sydney, NSW, Australia. · Pubmed 27863197
  • Division of Hematology and Oncology, University of California-Los Angeles, Los Angeles. · Department of Hematology/Oncology, The Angeles Clinic and Research Institute, Los Angeles, California. · Department of Hematology/Oncology, University of California-San Francisco, San Francisco. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital and Melanoma Institute Australia, Sydney, Australia7Department of Clinical Medicine, Macquarie University, Sydney, Australia. · Department of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada. · Department of Clinical Research, South Texas Accelerated Research Therapeutics, San Antonio. · Department of Melanoma, The University of Texas MD Anderson Cancer Center, Houston. · Department of Cutaneous Oncology, H. Lee Moffitt Cancer Center, Tampa, Florida. · Division of Hematology and Oncology, Abramson Cancer Center at the University of Pennsylvania, Philadelphia. · Department of Medicine, University of Sydney, Sydney, Australia. · Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota. · Department of Hematology/Oncology, Mayo Clinic, Jacksonville, Florida. · Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania. · Department of Hematology/Oncology, Massachusetts General Hospital, Boston. · Department of Medical Oncology, Gustave-Roussy Cancer Campus and Paris Sud University, Villejuif Paris-Sud, France. · Department of Clinical Oncology, Merck & Co, Inc, Kenilworth, New Jersey. · BARDS, Merck & Co, Inc, Kenilworth, New Jersey. · Pubmed 27092830
  • F. Stephen Hodi, Dana-Farber Cancer Institute, Boston, MA · Wen-Jen Hwu, The University of Texas MD Anderson Cancer Center, Houston · Amita Patnaik, South Texas Accelerated Research Therapeutics, San Antonio, TX · Richard Kefford, Westmead Hospital, Melanoma Institute Australia, and Macquarie University · Peter Hersey, University of Sydney, Sydney, Australia · Jeffrey S. Weber, H. Lee Moffitt Cancer Center, Tampa · Richard Joseph, Mayo Clinic, Jacksonville, FL · Adil Daud, University of California San Francisco, San Francisco · Omid Hamid, The Angeles Clinic and Research Institute · Antoni Ribas, University of California Los Angeles, Los Angeles, CA · Caroline Robert, Gustave-Roussy and Paris-Sud University, Villejuif-Paris-Sud, France · Tara C. Gangadhar, Abramson Cancer Center, Philadelphia, PA · Anthony M. Joshua, Princess Margaret Hospital, Toronto, Ontario, Canada · Roxana Dronca, Mayo Clinic, Rochester, MN · Darcy Hille, Dahai Xue, Xiaoyun Nicole Li, S. Peter Kang, Scot Ebbinghaus, and Andrea Perrone, Merck, Kenilworth, NJ · and Jedd D. Wolchok, Memorial Sloan Kettering Cancer Center, New York, NY. · Pubmed 26951310
2014
  • Mayo Graduate School, Mayo Clinic, Rochester, MN. · Oregon Health and Science University, Portland. · Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, MN. · Department of Oncology, Mayo Clinic, Rochester, MN. · Department of Oncology, Mayo Clinic, Rochester, MN; Department of Medicine, Division of Hematology, Mayo Clinic, Rochester, MN. Electronic address: · Pubmed 24684874
  • Department of Internal Medicine, Oakland University William Beaumont School of Medicine, Beaumont Health System, Royal Oak, MI. Electronic address: · Division of Medical Oncology, Mayo Clinic, Rochester, MN. · Pubmed 24684873
  • Gustave Roussy and INSERM U981, Paris-Sud, France. Electronic address: · University of California Los Angeles, Los Angeles, CA, USA. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · Angeles Clinic and Research Institute, Los Angeles, CA, USA. · Crown Princess Mary Cancer Centre, Westmead Hospital and Melanoma Institute Australia, Westmead, NSW, Australia; University of Sydney, Sydney, NSW, Australia. · H Lee Moffitt Cancer Center, Tampa, FL, USA. · Princess Margaret Cancer Centre, Toronto, ON, Canada. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA. · South Texas Accelerated Research Therapeutics, San Antonio, TX, USA. · Mayo Clinic, Rochester, MN, USA. · University of Pittsburgh, Pittsburgh, PA, USA. · Mayo Clinic, Jacksonville, FL, USA. · Gustave Roussy and INSERM U981, Paris-Sud, France. · Merck, Whitehouse Station, NJ, USA. · University of California San Francisco, San Francisco, CA, USA. · Pubmed 25034862
  • *Mayo Clinic Rochester, Rochester †Metro-Minnesota Community Clinical Oncology Program, St. Louis Park, MN ‡Mayo Clinic Arizona, Scottsdale, AZ §Columbus CCOP, Columbus, OH ∥Montana Cancer Consortium, Billings, MT. · Pubmed 23357973
  • Department of Dermatology, Mayo Clinic, Rochester, MN. · Division of Medical Oncology, Mayo Clinic, Rochester, MN. · Division of Medical Oncology, Mayo Clinic, Rochester, MN; Division of Hematology, Mayo Clinic, Rochester, MN; Division of Clinical Immunology and Immunotherapeutics, Mayo Clinic, Rochester, MN. · Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN. · Department of Dermatology, Mayo Clinic, Rochester, MN. Electronic address: · Pubmed 24388022
  • Mayo Clinic, Rochester, MN. · Pubmed 25092366
2012
  • Department of Medical Oncology, Mayo Clinic, Rochester, MN, USA. · Pubmed 23148614
2017
  • *Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA †The University of Texas MD Anderson Cancer Center, Houston, TX ‡Memorial Sloan Kettering Cancer Center §Weill Cornell Medical College §§NYU Clinical Cancer Center, New York, NY ∥The Angeles Clinic and Research Institute, Los Angeles ¶Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco ††The John Wayne Cancer Institute, Providence Saint John's Health Center, Santa Monica, CA #Mayo Clinic, Rochester, MN **Mayo Clinic, Jacksonville, FL ‡‡Dana-Farber Cancer Institute, Boston, MA ∥∥Yale Cancer Center, New Haven, CT ¶¶Clinigen, Weybridge, UK ##Merck & Co. Inc., Kenilworth, NJ ***Duke Cancer Institute, Durham, NC. · Pubmed 29028788
  • aDepartment of Health Science Research, Division of Biomedical Statistics and Informatics bDepartment of Medical Oncology cDepartment of Hematology, Mayo Clinic, Rochester, Minnesota, USA. · Pubmed 27824739
  • Departments of aOncology bRadiology cDepartment of Biomedical Statistics & Informatics, Mayo Clinic, Rochester, Minnesota, USA. · Pubmed 28296712
2016
  • Departments of aOncology bHematology cImmunology, Mayo Clinic, Rochester, Minnesota, USA. · Pubmed 26848796
2015
  • Departments of aInternal Medicine bOphthalmology cOncology, Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA. · Pubmed 25396683
2014
  • Departments of *Oncology †Surgery ‡Laboratory Medicine and Pathology §Ophthalmology #Dermatology ‡‡Radiation Oncology **Pediatrics §§Radiology ∥∥Hematology ¶¶Immunology ††Medical Genetics, Mayo Clinic, Rochester, MN ∥Department of Pediatric Hematology/Oncology, Hospital for Sick Children, Toronto, ON, Canada ¶The Queen's Medical Center/Queen's Cancer Center, University of Hawaii/John A. Burns School of Medicine, Honolulu, HI. · Pubmed 23563206
2012
  • Departments of Oncology Medicine, Division of Hematology Immunology Biomedical Statistics and Informatics Women's Health Clinic, Division of General Internal Medicine, Mayo Clinic Rochester, MN 55905, USA. · Pubmed 23039889
  • Division of Medical Oncology, Mayo Clinic, Rochester, MN 55905, USA. · Pubmed 23036672
  • Department of Health Science research, Mayo Clinic, Rochester, MN 55901, USA. · Pubmed 22201928
Mayo Clinic Scottsdale
2014
  • *Mayo Clinic Rochester, Rochester †Metro-Minnesota Community Clinical Oncology Program, St. Louis Park, MN ‡Mayo Clinic Arizona, Scottsdale, AZ §Columbus CCOP, Columbus, OH ∥Montana Cancer Consortium, Billings, MT. · Pubmed 23357973
16 Other Locations Show
Yearly article counts 02451714100
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.